28 related articles for article (PubMed ID: 9792976)
21. Evolving role of bone biomarkers in castration-resistant prostate cancer.
Brown JE; Sim S
Neoplasia; 2010 Sep; 12(9):685-96. PubMed ID: 20824045
[TBL] [Abstract][Full Text] [Related]
22. Alkaline phosphatase. A marker in prostatic cancer?
Høisaeter PA
Acta Oncol; 1991; 30(2):171-2. PubMed ID: 2029400
[No Abstract] [Full Text] [Related]
23. Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate.
Wolff JM; Ittel T; Borchers H; Brauers A; Jakse G
Urol Int; 1998 Oct; 61(1):12-6. PubMed ID: 9792976
[TBL] [Abstract][Full Text] [Related]
24. Prostate specific antigen in the diagnosis and staging of prostate cancer.
Jung P; Wolff JM; Mattelaer P; Jakse G
Acta Urol Belg; 1996 Sep; 64(3):1-6. PubMed ID: 8946774
[TBL] [Abstract][Full Text] [Related]
25. Prostatic specific antigen and bone scan in the diagnosis and follow-up of prostate cancer. Can diagnostic significance of PSA be increased?
Bantis A; Grammaticos P
Hell J Nucl Med; 2012; 15(3):241-6. PubMed ID: 23227460
[TBL] [Abstract][Full Text] [Related]
26. [Serum markers for early detection and staging of prostate cancer. Status report on current and future markers].
Haese A; Graefen M; Palisaar J; Huland E; Huland H
Urologe A; 2003 Sep; 42(9):1172-87. PubMed ID: 14504750
[TBL] [Abstract][Full Text] [Related]
27. Tumor markers in prostate cancer.
Cooper EH; Robinson MR; Whelan P; Ferro MA
Cancer; 1992 Jul; 70(1 Suppl):225-9. PubMed ID: 1376192
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]